Support

Lorem ipsum dolor sit amet:

24h / 365days

We offer support for our customers

Mon - Fri 8:00am - 5:00pm (GMT +1)

Get in touch

Cybersteel Inc.
376-293 City Road, Suite 600
San Francisco, CA 94102

Have any questions?
+44 1234 567 890

Drop us a line
info@yourdomain.com

About us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec.

Partners/Research Partners of Osteolabs

Evidence based.
Medically proven.

Learn more

Evidence based.
Medically proven.

Companion diagnostics

Companion diagnostics

A diagnostic test that is assigned to accompany a personalised drug therapy is called a Companion Diagnostics (CDx). There are many advantages of therapy-accompanying diagnostics. By means of an individual risk assessment, the side effects in treated patients are reduced. In addition, the existing status quo in the patient can be detected at an early stage of a disease, which enables earlier intervention and improves the chance of complete remission. Diagnoses can be made more accurately, as the same symptoms can be attributed to different causes. This enables specific, direct and effective therapy.

We are currently conducting studies for various manufacturers of osteoporosis drugs and for different groups of active substances, which can, among other things, test the effectiveness, possible dosages and the duration of the possible therapy.

For example, studies are currently underway in Kiel with the monoclonal antibody denosumab and in Leuven (Belgium) with androgen hormone inhibitors. Both studies are to be published in scientific journals in 2021. Do you also have a potential Companion Diagnostic project? Then contact our managing director Dr. Stefan Kloth.

Your contact person

We will be happy to answer any further questions you may have about
OsteoTest.
Footer logos